Dificlir is a medicine used to treat children and adults with infections of the gut caused by bacteria called Clostridioides difficile. Dificlir contains the active substance fidaxomicin.
Therapeutic Indication
### Therapeutic indication Dificlir film-coated tablets is indicated for the treatment of Clostridioides difficile infections (CDI) also known as C. difficile-associated diarrhoea (CDAD) in adult and paediatric patients with a body weight of at least 12.5 kg. Consideration should be given to official guidelines on the appropriate use of antibacterial agents. Dificlir granules for oral suspension is indicated for the treatment of Clostridioides difficile infections (CDI) also known as C. difficile-associated diarrhoea (CDAD) in adults and paediatric patients from birth to < 18 years of age. Consideration should be given to official guidelines on the appropriate use of antibacterial agents.
Therapeutic Area (MeSH)
ATC Code
A07AA12
ATC Item
fidaxomicin
Pharmacotherapeutic Group
Antidiarrheals, intestinal antiinflammatory / antiinfective agents
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| fidaxomicin | N/A | 非达米星 |
EMA Name
Dificlir
Medicine Name
Dificlir
Aliases
N/A
